Mitochondrial DNA Mutations in Hypertrophic Cardiomyopathy
Hidekazu Ino(Kanazawa University), Sumio Mizuno(Fukui CardioVascular Center), Hidenobu Terai(Kanazawa Hospital), Kotaro Ohe, Masato Yamaguchi(Jikei University School of Medicine), Kenshi Hayashi(Kanazawa University), Hiroshi Mabuchi(Koto Hospital), Tetsuo Konno(Kanazawa University), Masami Shimizu(Kanazawa University), Tomoya Kaneda(Tokyo Medical and Dental University), Tomohito Mabuchi(Fukui CardioVascular Center), Katsuharu Uchiyama(Kouseiren Takaoka Hospital)
Japanese Circulation Journal-english Edition
March 1, 2003
Cited by 0
Related Papers
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β
|Journal of Clinical Investigation|2010|440
T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity
|Clinical Science|2003|313
Idiopathic Pulmonary Fibrosis. Epidemiologic Approaches to Occupational Exposure
|American Journal of Respiratory and Critical Care Medicine|1994|269
T‐peak to T‐end interval may be a better predictor of high‐risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin i mutation than qt dispersion
|Clinical Cardiology|2002|267
Collagen remodelling in myocardia of patients with diabetes.
|Journal of Clinical Pathology|1993|247